FAQWhich is better for judging vitiligo — Wood’s lamp or dermoscopy?

FAQ

Which is better for judging vitiligo — Wood’s lamp or dermoscopy?

A recent study out of India compared the two head-to-head. Both tools correlated fairly well with clinical criteria, but dermoscopy had a slight edge:

  • Wood’s lamp: sensitivity 72.3%, specificity 66.7%. Correctly identified stable cases 87% of the time but was weak at ruling out unstable ones (44%).
  • Dermoscopy: sensitivity 74.1%, specificity 73.5%. Showed stronger overall accuracy, with an ROC of 0.826 vs 0.695 for Wood’s lamp. It also highlights perifollicular pigmentation, satellite lesions, and micro-Koebner changes — details that matter when planning surgery.

For clinicians: If you’re mainly screening or working in darker skin types, a Wood’s lamp is still useful, dirt-cheap (usually $50–150 for a decent handheld model), and portable.

Dermatoscopes are pricier (anywhere from $500–2,000 depending on optics and digital connectivity), but they give you much richer information and reproducible images — which can guide surgical timing, document progression, and support patient education.

Takeaway: In resource-limited settings or early practice, a Wood’s lamp is a fine start. But if you’re building a vitiligo-focused clinic, investing in a dermatoscope will pay off in precision and clinical confidence.

Suggested reading:

 

Published on August 22, 2025

FAQOther Questions

  • What's better: laser or phototherapy?

    Laser therapy is actually a type of phototherapy. Both rely on light to trigger changes in the skin, but they work differently. Phototherapy usually means a narrow-band UV (NB-...

  • How long does it take to treat vitiligo?

    Vitiligo, a condition characterized by the loss of skin pigment, can be unpredictable in both progression and treatment. The time it takes to treat vitiligo varies significantly...

  • Who is prone to vitiligo?

    Vitiligo can affect anyone, regardless of gender, age, or race. Vitiligo prevalence is between 0.76% and 1.11% of the U.S. population, including around 40% of those with the con...